Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.558 SEK | +2.64% | +2.64% | -8.24% |
Kurzporträt
Mitarbeiterzahl: 8
Umsatz nach Geschäftsbereich
SEK in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -12.43% |
Umsatz je Region
SEK in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -12.43% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Viktor Drvota
CEO | Chief Executive Officer | 59 | 07.12.15 |
Director of Finance/CFO | 56 | 01.10.22 | |
John Öhd
CTO | Chief Tech/Sci/R&D Officer | 53 | 01.06.20 |
Chief Investment Officer | 58 | 01.03.21 | |
Linda Spahiu
PRN | Corporate Officer/Principal | 39 | - |
Johan Dighed
LAW | General Counsel | 51 | 01.05.20 |
Corporate Officer/Principal | 59 | 01.11.15 | |
Eva Montgomerie
AUD | Comptroller/Controller/Auditor | 66 | 01.01.07 |
Thomas Andersson
PRN | Corporate Officer/Principal | 72 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Björn Cochlovius
CHM | Chairman | 56 | 01.01.20 |
Viktor Drvota
CEO | Chief Executive Officer | 59 | 07.12.15 |
Director/Board Member | 55 | 19.02.21 | |
Benjamin Toogood
BRD | Director/Board Member | 48 | 19.02.21 |
Theresa Tse
BRD | Director/Board Member | 32 | 28.11.17 |
Philip Duong
BRD | Director/Board Member | 34 | 12.01.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 10 | 2 555 261 | 0 | 0 | 35,96 % |
Aktie B | 1 | 267 522 333 | 97 108 178 ( 36,30 %) | 244 285 ( 0,0913 %) |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
OSSDSIGN AB 9,83% | 9 596 662 | 9,83% | 9 064 815 $ |
Unternehmenskontakt
Karolinska Development AB
Tomtebodavägen 23 A
171 65, Solna
+46 8 52 48 60 70
http://www.karolinskadevelopment.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. |
Biotechnology
|
Sektor
Verlauf des Gewinns je Aktie
Jahresgewinne - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
-8.24% | 37.56 Mio. | |
-2.92% | 185 Mrd. | |
-3.80% | 105 Mrd. | |
-5.48% | 66.59 Mrd. | |
+11.22% | 54.66 Mrd. | |
+16.74% | 47.78 Mrd. | |
+4.06% | 41.26 Mrd. | |
+4.56% | 26.95 Mrd. | |
+1.64% | 26.37 Mrd. | |
+12.96% | 24.8 Mrd. |
- Börse
- Aktien
- A0M84G Aktie
- Unternehmen Karolinska Development AB